StampPump: a Postage-Stamp Sized Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses
Award amount
$224,124Program and phase
STTR · Phase IAward year
2019Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Advanced Research Projects Agency
- Recipient company
- Thermalin Inc.
- Proposal award date
- 2019-03-25
- Contract end date
- 2020-01-24
- UEI
- NZ8VXJXMMMW6
- Solicitation number
- 18.C
- Topic code
- ST18C-004
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Disrupting Insulin Delivery with a Novel, Stabilized Insulin that is Ultra-rapid at U100 or U500
- StampPump:Proof of Principle for a Disruptive Insulin Delivery Technology
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of an Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses
- Development of Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses
- Genetically Engineered Pancreatic Organoids Composed of Extracellular Matrix Hydrogels for the Purpose of Long-Term Therapeutic Glycemic Maintenance
- Building an Autonomous Glycemic Control System for Hyperglycemia of Critical Illness
Research funding history
3 SBIR/STTR records share this UEI (2019–2020). Reported award amounts total $3,494,632. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense